Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Watson Pharmaceuticals Shares

Watson Pharmaceuticals Shares Newsletter

Generic drugmaker Endo 2018 forecast disappoints, shares drop 27 Feb 2018 15:00 GMT
… and increased competition, sending its shares down nearly 5 percent in … Plc’s (AGN.N) unit, Watson Pharmaceuticals Inc, to delay launching a … 8 percent. The company’s shares were down 4.7 percent …
Watson Pharmaceuticals To Buy Arrow Group For $1.75 Billion 17 Jun 2009 23:14 GMT
… 17, 2009 (FinancialWire) — Watson Pharmaceuticals, Inc. (NYSE: WPI) said it … of around 16.9 million shares of Watson common stock valued … ;p>Corona, California-based Watson Pharmaceuticals is engaged in the development …
Erythropoietin (EPO) Drugs Market Forecast To Surge USD 12.5 Billion By 2033, Driven By 5.20% CAGR 07 Feb 2025 09:58 GMT
… resources to maintain significant shares through innovative drug formulations … resources to maintain significant shares through innovative drug formulations … Celltrion Inc. •Hospira Inc. •Watson Pharmaceuticals •GlycoMimetics Inc. •Akebia Therapeutics …
Chronic Liver Diseases Therapeutics Market to See Growth 2024-2031 | Astellas Pharma ,Bristol-Myers Squibb, Sanofi S.A 19 Jan 2024 14:12 GMT
… Inc., Takeda Pharmaceutical, Valeant Pharmaceuticals, Watson Pharmaceuticals, Inc., Theratechnologies Inc., Alnylam Pharmaceuticals … employed to determine their market shares. All percentage share splits and …
Asia Pacific Generic Medicine Market Size, Share, Value, And Competitive Landscape - 2022-2031 02 Aug 2022 09:05 GMT
… the market. The report additionally shares critical insights on the COVID … ., Par Pharmaceutical, Inc., Celgne Corporation, Watson Pharmaceuticals, Ltd., Actavis, Dr. Reddy…
Organ Transplant Immunosuppressant Drugs Market Generated Opportunities, Future Scope 2022-2028 | Astellas Pharma 13 Apr 2022 10:24 GMT
… , Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories … both value and volume ‣ Market shares and strategies of key players …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS